Dyne Therapeutics's market cap is currently $2.00B. The company's EPS TTM is $-0.97; its P/E ratio is ―; Dyne Therapeutics is scheduled to report earnings on July 28, 2025, and the estimated EPS forecast is $-0.84. See an overview of income statement, balance sheet, and cash flow financials.
